KRITO PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
KRITO PHARMA
NACE 64.210, Activities of holding companies
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€79,606
2024 · €30,352+€49,254
Equity
€359,179
2024 · €357,573+€1,606
Cash
€36,516
2024 · €40,225-€3,709
Balance sheet total
€2.0m
2024 · €2.1m-€39,776
Largest movements
Assets
- Tangible fixed assets -€21,609
down €21,609 (-4.8%), from €447,403 to €425,794
of which Land and buildings: -€18,810
Equity and liabilities
- Debts after one year -€131,585
down €131,585 (-18.6%), from €705,918 to €574,332
- Other debts +€101,539
up €101,539 (+12.5%), from €810,199 to €911,738
Income statement
- Gross operating margin +€31,243
up €31,243 (+15.0%), from €208,635 to €239,878
- Staff costs -€10,049
down €10,049 (-8.5%), from €118,730 to €108,681
- Taxes -€6,793
down €6,793 (-78.8%), from €8,618 to €1,825
- Financial charges -€2,633
down €2,633 (-9.3%), from €28,258 to €25,626
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€30,352
Gross operating margin
+€31,243
Staff costs
+€10,049
Depreciation
-€1,429
Other operating charges
-€32
Financial income
-€2
Financial charges
+€2,633
Taxes
+€6,793
Result 2025
€79,606
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€202,051
Investment
€0
Financing
-€205,760
Cash 2024
€40,225
From operations (derived)
+€202,051
Net result for the year
+€79,606
Depreciation
+€21,609
Receivables within one year
+€16,352
Deferred charges and accrued income
-€1,893
Trade debts
-€9,539
Tax, wage and social debts
-€5,952
Other debts
+€101,539
Accrued charges and deferred income
+€330
Financing
-€205,760
Debts after one year
-€131,585
Current portion of long-term debt
+€3,825
Contributions, distributions and other
-€78,000
Cash 2025
€36,516
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,052,098 | €2,012,321 | -€39,776 | -1.9% |
| Fixed assets | 21/28 | €1,837,603 | €1,815,994 | -€21,609 | -1.2% |
| Tangible fixed assets | 22/27 | €447,403 | €425,794 | -€21,609 | -4.8% |
| Land and buildings | 22 | €433,455 | €414,645 | -€18,810 | -4.3% |
| Plant, machinery and equipment | 23 | €13,948 | €11,149 | -€2,799 | -20.1% |
| Financial fixed assets | 28 | €1,390,200 | €1,390,200 | = | 0.0% |
| Current assets | 29/58 | €214,495 | €196,327 | -€18,168 | -8.5% |
| Amounts receivable within one year | 40/41 | €173,820 | €157,468 | -€16,352 | -9.4% |
| Trade receivables | 40 | €16,542 | €37,398 | +€20,856 | +126% |
| Other amounts receivable | 41 | €157,278 | €120,070 | -€37,208 | -23.7% |
| Cash at bank and in hand | 54/58 | €40,225 | €36,516 | -€3,709 | -9.2% |
| Deferred charges and accrued income | 490/1 | €450 | €2,343 | +€1,893 | +421% |
| Total equity and liabilities | 10/49 | €2,052,098 | €2,012,321 | -€39,776 | -1.9% |
| Equity | 10/15 | €357,573 | €359,179 | +€1,606 | +0.4% |
| Contributions | 10/11 | €120,000 | €120,000 | = | 0.0% |
| Reserves | 13 | €17,500 | €17,500 | = | 0.0% |
| Distributable reserves | 133 | €17,500 | €17,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €220,073 | €221,679 | +€1,606 | +0.7% |
| Amounts payable | 17/49 | €1,694,525 | €1,653,142 | -€41,382 | -2.4% |
| Amounts payable after more than one year | 17 | €705,918 | €574,332 | -€131,585 | -18.6% |
| Financial debts | 170/4 | €705,918 | €574,332 | -€131,585 | -18.6% |
| Amounts payable within one year | 42/48 | €985,619 | €1,075,493 | +€89,874 | +9.1% |
| Current portion of amounts payable after more than one year | 42 | €130,716 | €134,542 | +€3,825 | +2.9% |
| Trade debts | 44 | €28,238 | €18,699 | -€9,539 | -33.8% |
| Suppliers | 440/4 | €28,238 | €18,699 | -€9,539 | -33.8% |
| Taxes, remuneration and social security | 45 | €16,466 | €10,514 | -€5,952 | -36.1% |
| Taxes | 450/3 | €2,996 | €2,648 | -€348 | -11.6% |
| Remuneration and social security | 454/9 | €13,469 | €7,865 | -€5,604 | -41.6% |
| Other amounts payable | 47/48 | €810,199 | €911,738 | +€101,539 | +12.5% |
| Accrued charges and deferred income | 492/3 | €2,988 | €3,318 | +€330 | +11.0% |
| Remuneration, social security and pensions | 62 | €118,730 | €108,681 | -€10,049 | -8.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €20,180 | €21,609 | +€1,429 | +7.1% |
| Other operating charges | 640/8 | €2,503 | €2,536 | +€32 | +1.3% |
| Gross operating margin | 9900 | €208,635 | €239,878 | +€31,243 | +15.0% |
| Operating profit (loss) | 9901 | €67,222 | €107,053 | +€39,831 | +59.3% |
| Financial income | 75/76B | €6 | €4 | -€2 | -38.7% |
| Recurring financial income | 75 | €6 | €4 | -€2 | -38.7% |
| Financial charges | 65/66B | €28,258 | €25,626 | -€2,633 | -9.3% |
| Recurring financial charges | 65 | €28,258 | €25,626 | -€2,633 | -9.3% |
| Profit (loss) for the period before taxes | 9903 | €38,970 | €81,431 | +€42,461 | +109% |
| Income taxes | 67/77 | €8,618 | €1,825 | -€6,793 | -78.8% |
| Profit (loss) for the period | 9904 | €30,352 | €79,606 | +€49,254 | +162% |
| Profit (loss) for the period to be appropriated | 9905 | €30,352 | €79,606 | +€49,254 | +162% |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.